Basecamp Research raises $140 million to train AI on the planet's DNA
Two frontier labs spent Tuesday undercutting each other's token prices. The round that might matter longer went to a company teaching AI to read DNA no public database has ever seen.
Basecamp Research, the London startup building biological foundation models from wild DNA, has raised a $140 million Series C led by S32 — a round Reuters reports values the company at $800 million. Nvidia's NVentures, Anthropic's Anthology Fund, the NATO Innovation Fund, the Rockefeller Foundation, Redalpine and True Ventures all joined. The asset is data: EDEN, Basecamp's model family, trains on genetic material collected with local researchers in more than 30 countries across all seven continents — rainforest soil, volcanic ground, Antarctic seafloor — which the company says adds up to over 10 billion new genes, roughly ten times the content of all public sequence databases combined.
The proof point is a molecule. In June, the company reported that EDEN-7, an antibiotic the model designed straight from a pathogen prompt with no manual tweaking, worked about as well as a last-resort antibiotic in mice infected with multidrug-resistant bacteria, in a collaboration with the University of Pennsylvania. Early testing put 97 percent of the model's designed peptide candidates as lab-active — though the mouse work isn't peer-reviewed, and none of Basecamp's six therapy programs has moved past lead optimization. The signal investors are buying is bigger than any pipeline: the next scaling run in AI isn't hiding on the internet, it's in soil. The company's Trillion Gene Atlas project, built with Anthropic, Nvidia, PacBio and Ultima Genomics, aims to grow the dataset a hundredfold toward 100 million species.
Sony Music Group has become the first music company to join ARIAM, the creative-industry coalition for responsible AI that already counts Disney, the New York Times, the BBC and Adobe among its members. "We're very excited to welcome Sony Music Group as the first music company to join ARIAM," the alliance's chief executive Victoria Furniss said in Wednesday's announcement. The timing is the story: Sony is the only major label without a licensing deal with Suno or Udio, and it filed a second lawsuit against Suno alongside UMG just days ago. In its statement, Sony argued that a healthy licensing market — where AI companies proactively partner with rightsholders — is the only foundation for getting generative music right. Litigation to price the infringement, coalitions to shape the rules: the majors are now running both tracks at once.
And the other half of Tuesday's double launch deserves its own tally: Anthropic's Opus 5.5 didn't just cost less — it debuted at the top of Artificial Analysis' Intelligence Index, scoring 58 at max effort, the highest score the benchmark has measured. Pricing dropped to $4 per million input tokens and $20 for output, down from $5 and $25, with cache reads cut from $0.50 to $0.20; Anthropic claims Fable 5.1-level performance on most tasks, about 30 percent faster output, and a 20 percent bump to five-hour usage limits plus a banked reset. METR has published a predeployment evaluation, and Sonnet 5.5 and Haiku 5.5 are reportedly due within weeks. We covered the OpenAI side when it broke — OpenAI halves GPT-6 Sol and Luna prices hours after Anthropic's cut — and the pattern is now unmistakable: the "pace the frontier" essay was days old when Anthropic shipped a cheaper, faster flagship.
What to watch: whether Sonnet 5.5 and Haiku 5.5 inherit the price cuts — and whether OpenAI answers with an Astra-tier discount of its own.
Would a $4 frontier model change what you build — or just what you can afford to run all night? Tell us in the comments.
Sources: The Decoder · Reuters (via Yahoo Finance) · Genetic Engineering & Biotechnology News · Basecamp Research · Variety · Music Business Worldwide · ARIAM · Anthropic · Artificial Analysis · METR
